Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-18

FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lorazepam from Hikma Pharmaceuticals USA Inc., indicating an approved update to the drug's labeling or authoriza…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)